edgepedia

Life science in China, India, and Asia-Pacific

86 articles

ABL Bio

ABL Bio (에이비엘바이오) is a Seoul-based South Korean biotechnology company, founded by Sang Hoon Lee in 2016, that develops bispecific antibodies for cancer and neurodegenerative diseases.

Agilus Diagnostics

Agilus Diagnostics, formerly SRL Diagnostics, is an Indian diagnostics company promoted by Fortis Healthcare, second largest in India by revenue, with 413 laboratories and over 3,800 tests.

Ajay Bhardwaj

Ajay Bhardwaj, born 1960, is an Indian entrepreneur who founded Anthem Biosciences, a Bengaluru-based contract research, development, and manufacturing organization, after more than 21 years at Biocon.

Akeso

Akeso (康方生物) is a Chinese biopharmaceutical company founded in 2012 in Zhongshan, Guangdong, known for cadonilimab and ivonescimab, whose ivonescimab beat pembrolizumab in a phase 3 lung-cancer trial.

Allist Pharmaceuticals

Allist Pharmaceuticals (艾力斯) is a Chinese biopharmaceutical company founded in Shanghai's Zhangjiang Hi-Tech Park in 2004, best known for furmonertinib, a lung cancer drug licensed internationally to ArriVent Biopharma.

Alteogen

Alteogen is a South Korean biotechnology company founded in Daejeon in 2008 by Park Soon-jae, known for its Hybrozyme platform, which Merck chose for a subcutaneous version of Keytruda.

Anand K.

Anand K. is an Indian healthcare executive who served as chief executive of SRL Diagnostics from 2020, leading its 2023 rebranding to Agilus Diagnostics, until stepping down in 2026.

Anthem Biosciences

Anthem Biosciences is a Bangalore-based contract research, development, and manufacturing organization founded in 2006 by Ajay Bhardwaj and others, serving pharma and biotech clients from drug discovery through commercial manufacturing.

Apollo Diagnostics

Apollo Diagnostics is an Indian diagnostics network operated by Apollo Health and Lifestyle Limited, a subsidiary of Apollo Hospitals Enterprise, linking franchised collection centers to central laboratories.

Aprogen

Aprogen (에이프로젠) is a South Korean biopharmaceutical company founded in April 2000 that develops antibody biosimilars and novel antibody drugs, and was named Korea's first biopharmaceutical unicorn in January 2020.

Aristo Pharmaceuticals

Aristo Pharmaceuticals is an unlisted Indian pharmaceutical company founded by Mahendra Prasad in Mumbai in 1971, best known for the Monocef antibiotic and Pantop brands.

Ascletis Pharma

Ascletis Pharma is a Chinese biopharmaceutical company founded and led by Jinzi Jason Wu, known for the hepatitis C drug Ganovo and the oral GLP-1 obesity drug ASC30.

Ben Chien

Ben Chien (简铭达, also Chien Ming-Ta) is a Taiwanese-American pharmaceutical executive, founder, chairman, and CEO of Foresee Pharmaceuticals, a Taiwan biotech making long-acting injectable drugs.

Cao Lin (biochemist)

Cao Lin (曹林), also rendered Lin Cao, is a Chinese biochemist and entrepreneur who founded the reagent maker Vazyme in Nanjing in 2012 and chairs it.

Celltrion

Celltrion (셀트리온) is a South Korean biopharmaceutical company founded by Seo Jung-jin that makes biosimilars, including Remsima, approved in Europe in 2013 as the world's first monoclonal-antibody biosimilar.

Cen Junda

Cen Junda (岑均达), born 1964, is a low-profile Chinese pharmaceutical investor who holds major stakes in Hansoh Pharmaceutical and Jiangsu Hengrui Pharmaceuticals, with an estimated fortune of US$5.6 billion.

D&D Pharmatech

D&D Pharmatech (디앤디파마텍) is a South Korean biotechnology company developing peptide therapeutics for obesity, liver fibrosis, and neurodegenerative disorders, founded by Seulki Lee in 2014.

Deepak Sahni

Deepak Sahni is an Indian entrepreneur who founded Healthians, an at-home health-testing company offering blood tests and screenings, which grew to more than 250 cities in India.

Divi's Laboratories

Divi's Laboratories is a Hyderabad-based Indian pharmaceutical company founded by Murli Divi in 1990, a leading maker of generic APIs and custom-synthesis partner for global drug companies.

Dr. Lal PathLabs

Dr. Lal PathLabs is an Indian diagnostics company founded in New Delhi in 1949 by Dr. Major S. K. Lal, operating one of India's largest testing laboratory networks.

Du Jinhao

Du Jinhao (杜锦豪, born 1954) is a Chinese entrepreneur who co-founded Shanghai Allist Pharmaceuticals, an oncology company listed on the STAR Market in 2020, and has been its chairman since 2004.

Gracias Saldanha

Gracias Saldanha (1938–2012) was an Indian pharmaceutical entrepreneur who founded Glenmark Pharmaceuticals in Mumbai in 1977 with one million rupees and built it into a top-100 global drug company.

Guo Jianhui

Guo Jianhui (郭建辉), also listed as Jeffrey Yang Guo, was a tenured NIH scientist who co-founded Shanghai Allist Pharmaceuticals in Shanghai in 2004 and died of illness in 2012.

Han Yusheng

Han Yusheng (汉雨生) is the founder, chairman, and CEO of Burning Rock Biotech, a Guangzhou cancer-testing company that became the first China-based oncology NGS firm on Nasdaq in 2020.

Hansoh Pharmaceutical

Hansoh Pharmaceutical, known as Hansoh Pharma, is a Chinese pharmaceutical company built by Zhong Huijuan from a 1995 joint venture in Lianyungang, focused on innovative cancer drugs.

Healthians

Healthians is an Indian at-home diagnostics company founded by Deepak Sahni in 2014 that collects samples at customers' homes and runs its own NABL- and CAP-accredited labs.

Henlius

Henlius (复宏汉霖), formally Shanghai Henlius Biotech, is a Shanghai biopharmaceutical company founded in 2010 with Fosun Pharma, known for biosimilars and serplulimab, the first anti-PD-1 approved for first-line small cell lung cancer.

Hong Hao

Hong Hao (洪浩) is a Chinese-American chemist and entrepreneur who founded Asymchem Laboratories in North Carolina in 1995, then built it in Tianjin, China, into one of the country's largest pharmaceutical contract manufacturers.

Hong Ye

Hong Ye (叶红) is a Chinese businesswoman who co-founded Peijia Medical (沛嘉医疗), a Suzhou-based developer of transcatheter heart valves and neurointerventional devices, and serves as an executive Director.

Huamao Wang

Huamao Wang (王华茂) is a Chinese cell-therapy scientist and executive who co-founded Shanghai CAR-T developer CARsgen Therapeutics in 2014 and serves as its chief operating officer.